Spire Biomedical seeks suitor:
This article was originally published in Clinica
The Spire group of companies, which includes Spire Biomedical, has hired OEM Capital to review its options, including merger or sale. Bedford, Massachusetts-based Spire Biomedical specialises in surface treatments to improve the performance of medical devices such as heart valves, catheters, and orthopaedic components, using proprietary ion beam technology.
You may also be interested in...
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.